80 81

An ne

x 1 .

D at

a Ta

bl e

H um

an re

so ur

ce s/

w or

kf or

ce

Es ta

bl is

hm en

ts Ed

uc at

io n

FIP Global Pharmacy Workforce Report 2012

Ph ar

m ac

is ts

To ta

l l ic

en se

d To

ta l f

em al

e lic

en se

d N

ew ly

lic en

se d/

ye ar

To ta

l

Ph ar

m ac

y te

ch ni

ci an

s

Ph ar

m ac

y te

ch ni

ci an

s

To ta

l Ph

ar m

ac ie

s Co

m m

un it

y Ph

ar m

ac ie

s Ph

ar m

ac ie

s gr

ad ua

te s/

ye ar

Sc ho

ol s

Ph ar

m ac

y

Ph ar

m ac

y te

ch ni

ci an

: A p

er so

n w

ho s

up po

rt s

ph ar

m ac

is ts

in

th e

de liv

er y

of p

ha rm

ac y*

s er

vi ce

s. A

ls o

in cl

ud es

q ua

lifi ed

as

si st

iv e

pe rs

on ne

l s uc

h as

p ha

rm ac

y te

ch no

lo gi

st s.

Ph ar

m ac

ie s:

P re

m is

es w

hi ch

in a

cc or

da nc

e to

th e

lo ca

l l eg

al

pr ov

is io

ns a

nd d

efi ni

ti on

s m

ay o

pe ra

te a

s a

fa ci

lit y

in th

e pr

ov is

io n

of p

ha rm

ac y

se rv

ic es

in th

e co

m m

un it

y or

h os

pi ta

l s et

ti ng

s.

D efi

ni ti

on s

Ph ar

m ac

is t:

A pr

of es

si on

al w

ho in

a cc

or da

nc e

to th

e lo

ca l l

eg al

p ro

vi si

on s

an d

de fin

it io

ns m

ay p

ro vi

de p

ha rm

ac y

se rv

ic es

(i n

th e

co m

m un

it y,

h os

pi ta

l, ac

ad em

ia , r

es ea

rc h,

in du

st ry

e tc

) i n

yo ur

c ou

nt ry

.

Li ce

ns ed

: R eg

is te

re d

to p

ro vi

de

ph ar

m ac

y se

rv ic

es .

N ot

es (h

yp he

n) : D

at a

no t a

va ila

bl e

* : E

st im

at ed

d at

a ◊

D at

a on

ly re

po rt

ed b

y th

e Re

pu bl

ik a

Sr ps

ka ,

on e

of th

e tw

o en

ti ti

es fo

rm in

g Bo

sn ia

a nd

H er

ze go

vi na

. Ye

ar a

nd d

at a

so ur

ce o

f d at

a va

ry .

U ga

nd a

55

0

10 0

10

6 50

6 00

8 00

5 5

3

1

U kr

ai ne

40 00

0

34 80

0*

50

00 *

-

2 25

55 �

-

1

50 0

1

6

5 4

U ru

gu ay

1 36

5*

1 02

2*

30

* �

-

11

94 *

1 10

0*

30

*

1

3

U SA

27 50

00

12 76

00

12

00 0

50 00

00 *

� �

-

-

1 30

00

12 7

7 00

*

Va nu

at u

3

5

1

7

0

23

1

4

9

0

0

0

Vi et

na m

1 20

00

8 00

0 �

-

5

00 00

*

4 36

29

9 03

7

1 20

0

7

6 4

Za m

bi a

25

0*

1 02

*

3

6*

15 00

*

5 00

0*

1 20

*

4

5*

1

1

Zi m

ba bw

e

67 8

-

8

2

18 50

6 33

3

75

6

5

1

2

Annex 2: Acknowledgements

Afghanistan Abdul Khalid Amini, Management Sciences for Health, SPS; Ministry

of Public Health.

Albania Etleva Ruci (Taga), Pharmacists Order of Albania.

Australia Stephen Armstrong and Patrick Reid, Pharmacy Guild of Australia.

Bangladesh Mohammad Kawsar Sharif Siam, Pharmacy Students Society of

Bangladesh.

Belgium Jan Saevels, Association Pharmaceutique Belge.

Bhutan Ngawang Dema, Drug Regulatory Authority; Sangay Wangmo, Jigme Dorji

Wangchuck, National Referral Hospital.

Bolivia Lilia Verazain, Caja de Salud de la Banca Privada.

Bosnia and Herzegovina Republic of Srpska Pharmaceutical Association

of Republic of Srpska.

Burundi Bonaventure Nyabenda, Département de la Pharmacie, du Médicament

et des Laboratoires au Ministère de la Santé Publique et de la Lutte contre le Sida;

Conseil National de l Ordre des Pharmaciens.

Cambodia Sokhan Chroeng, Pharmacists Association of Cambodia.

Cameroon Bwemba Therese Abong, Ordre National des Pharmaciens

du Cameroun.

Canada Janet Cooper, Canadian Pharmacists Association.

Chile Adriana Patricia Acuña�Johnson, Faculty of Pharmacy, University

of Valparaiso.

China Dechun Jiang, Chinese Pharmaceutical Association.

China Taiwan Michael Wei�Chih Liu, Pharmaceutical Society of Taiwan.

Congo (Dem. Rep. of) Ray Mankele, Médicaments Essentiels et Technologies

de Santé, OMS.

Cook Islands Biribo Tekanene, Ministry of Health.

Costa Rica Adriana Figueroa, Colegio de Farmacéuticos de Costa Rica.

Croatia Danijela Jonjić, Croatian Chamber of Pharmacists; Croatian Pharmaceutical Society.

Cuba Deyanira Carnesoltas�Lázaro, Instituto Nacional de Oncologia

y Radiobiologia.

Czech Republic Stanislav Havlicek, Czech Chamber of Pharmacists; Veronika

Sumpichova.

Denmark Helle Jacobsen, Association of Danish Pharmacies.

Egypt Adel Sakr, Future University, Egypt; Waleed Shawky, Cairo Chamber

of Commerce; Seham Elkheshen, Faculty of Pharmaceutical Sciences

and Pharmaceutical Industries.

Ethiopia Edmealem Ejigu, Kidu Gebremedhin and Ariaya Hymete, Ethiopian

Pharmaceutical Association.

Fiji Islands Apolosi Vosanibola, Fiji Pharmaceutical and Biomedical Supplies Center

Finland Sanna Passi, Finnish Pharmacists Association.

France Hélène Leblanc, Ordre National des Pharmaciens.

Germany Berit Eyrich, Bundesvereinigung Deutscher Apothekerverbände (ABDA:

Federal Union of German Associations of Pharmacists).

Ghana Daniel Danquah, Pharmacy Council.

Great Britain Christopher John, Royal Pharmaceutical Society.

Grenada Anthony Cyrus, Pharmacy Council.

Guinea (Republic of) Cécé Vieux Kolié, Ministère de la Santé.

Hong Kong SAR, China Benjamin Tak Yuen Chan, Open University of Hong Kong,

Li Ka Shing Institute of Professional and Continuing Education.

Hungary Georgina Gal.

Iceland Ingunn Björnsdóttir, Pharmaceutical Society of Iceland; Helga

Gardarsdottir.

India Akashna Anand, O&M; Manjiri Gharat,Indian Pharmaceutical Association;

Anantha Naik Nagappa, Association of Community Pharmacists of India;

GuruPrasad Mohanta, Annamalai University; Habeeb Ibrahim Abdul Razack,

Accenture Services Ltd.

Iran Maryam Nakhjavani, Iranian Association of Pharmaceutical Scientists

(IranAPS).

Ireland Lorraine Horgan, Pharmaceutical Society of Ireland.

Israel Howard Rice, Pharmaceutical Association of Israel.

Italy Mauro Lanzilotto, Federfarma.

Japan Yoshiteru Watanabe, Showa Pharmaceutical University; Japan

Pharmaceutical Association.

Jordan Mohammad Ababneh, Jordan Pharmaceutical Association; Lina Bader,

University of Nottingham, United Kingdom.

Kenya Stephen Kimatu, Pharmacy & Poisons Board; Elizabeth Ominde�Ogaja,

Ministry of Medical Services.

Korea (Republic of) Hyun�Seung Kim, The Korean Pharmaceutical Association.

Lithuania Svitrigaile Grinceviciene, Lithuanian University of Health Science.

Macedonia (FYROM) Jasminka Patcheva, Pharmaceutical Chamber of Macedonia.

Malawi Stanley Chitukwi, OSSEDI Malawi; Zoe Lim, University of Nottingham.

Malaysia John Chang, Malaysian Pharmaceutical Society; Nur Azhana Abdullah,

Pharmaceutical Services Division, Ministry of Health.

Mali Abdou Doumbia, Ordre des Pharmaciens; Ndahirou Tall, Chu Gabriel Touré.

Malta Lilian M Azzopardi, University of Malta.

Marshall Islands (Republic of the) Filipo Samunaka, Majuro Hospital, Ministry

of Health.

Mauritius Sudhir Misri, Pharmaceutical Association of Mauritius.

Mexico Ana María Téllez López, Universidad Autónoma del Estado de Hidalgo;

Eduardo Teodoro Delint Ramírez, Secretaría de Salud Federal Dirección General

de Planeación y Desarrollo en Salud (DGPlaDeS); Fela Viso Gurovich, Lucila Isabel

Castro Pastrana, Asociación Mexicana de Farmacéuticos de Hospital.

Moldova (Republic of) Zinaida Bezverhni, State University of Medicine

and Pharmacy Nicolae Testemitanu .

Nauru Leweni Mocevakaca, Ministry of Health Nauru.

Nepal Panna Thapa, KU School of Science, Department of Pharmacy, Kathmandu

University; Uttam Budhathoki, Department of Pharmacy, Kathmandu

University/Nepal Pharmaceutical Association.

Netherlands Frans van de Vaart, KNMP/Royal Dutch Association for the

advancement of Pharmacy; Huub Overgaag, KNMP.